中文

News

Qilu Pharmaceutical Awarded as the Best R&D Pipeline Pharmaceutical Company
Qilu Pharmaceutical Ranked No. 9 among Top 100 Chinese Pharmaceutical Companies
Qilu Pharmaceutical Acquired an Exclusive Right for the Development and Commercialization of Vicineum™ in Greater China
Abiraterone Acetate Tablets exported to US
The first Avastin(Bevacizumab) Biosimilar approval in China granted by NMPA
Qilu Pharmaceutical Ranks No. 8th among Top 100 Chinese Pharmaceutical Companies
Qilu Pharmaceutical recognized as Top 3 domestic R&D pharmaceutical company of 2019

PRODUCTS

MANUFACTURING

NEWS

CONTACT US

R&D 

ABOUT US

Copyright(c)2019 Qilu Pharmaceutical Co., Ltd. 鲁ICP备06006222号 Headquarter Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China